Search research articles
Contact Us
Filters
Showing results (1051-1060 of 1,104) with videos related to
Page
of 111
Sort By:
Blood Cancer Journal
|
October 6, 2025
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)
Jin Seok Kim, Yang Song, Wei-Ying Jen, et al.
BMC Cancer
|
June 3, 2021
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial
Stefan Knop, Maria-Victoria Mateos, Meletios A Dimopoulos, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2024
Protonation-Driven Polarization Retention Failure in Nano-Columnar Lead-Free Ferroelectric Thin Films
Muhammad Sheeraz, Chang Won Ahn, Nguyen Xuan Duong, et al.
Blood Advances
|
April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial
Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
International Journal of Hematology
|
September 5, 2003
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial
Myung-Ju Ahn, Jung-Hye Choi, Young-Yeul Lee, et al.
Annals of Hematology
|
January 15, 2021
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial
Ji Hyun Lee, Yong Park, Ka-Won Kang, et al.
Cancer Genetics and Cytogenetics
|
March 3, 2010
Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia
Soo-Mee Bang, Ji-Weon Seo, Kyung Un Park, et al.
Annals of Hematology
|
September 13, 2013
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients
Kihyun Kim, Seok Jin Kim, Verena Voelter, et al.
American Journal of Hematology
|
February 12, 2024
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, et al.
Annals of Hematology
|
February 25, 2010
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib
Youngil Koh, Inho Kim, Sung-Soo Yoon, et al.
Page
of 111
Search research articles
Search
Showing results (1051-1060 of 1,104) with videos related to
Sort By:
Page
of 111
Blood Cancer Journal
|
October 6, 2025
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)
Jin Seok Kim, Yang Song, Wei-Ying Jen, et al.
BMC Cancer
|
June 3, 2021
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial
Stefan Knop, Maria-Victoria Mateos, Meletios A Dimopoulos, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2024
Protonation-Driven Polarization Retention Failure in Nano-Columnar Lead-Free Ferroelectric Thin Films
Muhammad Sheeraz, Chang Won Ahn, Nguyen Xuan Duong, et al.
Blood Advances
|
April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial
Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
International Journal of Hematology
|
September 5, 2003
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial
Myung-Ju Ahn, Jung-Hye Choi, Young-Yeul Lee, et al.
Annals of Hematology
|
January 15, 2021
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial
Ji Hyun Lee, Yong Park, Ka-Won Kang, et al.
Cancer Genetics and Cytogenetics
|
March 3, 2010
Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia
Soo-Mee Bang, Ji-Weon Seo, Kyung Un Park, et al.
Annals of Hematology
|
September 13, 2013
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients
Kihyun Kim, Seok Jin Kim, Verena Voelter, et al.
American Journal of Hematology
|
February 12, 2024
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, et al.
Annals of Hematology
|
February 25, 2010
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib
Youngil Koh, Inho Kim, Sung-Soo Yoon, et al.
Page
of 111